NovaBay Pharmaceuticals I...

AMEX: NBY · Real-Time Price · USD
0.61
0.01 (0.86%)
At close: Aug 15, 2025, 1:23 PM

NovaBay Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
430K 3.13M 5.36M 7.5M
Short-Term Investments
n/a n/a n/a n/a
Long-Term Investments
n/a n/a 484K 475K
Other Long-Term Assets
480K 497K 489K 476K
Receivables
389K 759K 1.97M 1.67M
Inventory
765K 2.88M 3.44M 3.22M
Other Current Assets
158K 81K 159K 129K
Total Current Assets
1.94M 7.15M 11.33M 13.17M
Property-Plant & Equipment
1.01M 1.38M 1.95M 604K
Goodwill & Intangibles
n/a n/a 2.63M 9.73M
Total Long-Term Assets
1.49M 1.88M 5.07M 10.81M
Total Assets
3.42M 9.03M 16.4M 23.98M
Account Payables
623K 1.13M 1.08M 1.04M
Deferred Revenue
488K n/a 1.81M 1.29M
Short-Term Debt
565K 1.14M 453K 305K
Other Current Liabilities
172K 1.18M 406K 320K
Total Current Liabilities
2.84M 4.28M 4.26M 3.44M
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
n/a 334K n/a 10.12M
Total Long-Term Liabilities
709K 1.44M 1.59M 10.37M
Total Liabilities
3.55M 5.72M 5.84M 13.81M
Total Debt
1.67M 2.74M 2.04M 551K
Common Stock
49K 112K 652K 478K
Retained Earnings
-183.46M -174.85M -158.15M -141.89M
Comprehensive Income
n/a n/a n/a n/a
Shareholders Equity
-129K 3.31M 10.55M 10.17M
Total Investments
n/a 476K 484K 475K